Filing Details

Accession Number:
0001209191-19-003464
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-11 18:15:19
Reporting Period:
2019-01-11
Accepted Time:
2019-01-11 18:15:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879407 Arrowhead Pharmaceuticals Inc. ARWR Pharmaceutical Preparations (2834) 460408024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553338 D. William Waddill 225 S. Lake Avenue
Suite 1050
Pasadena CA 91101
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-01-11 8,500 $14.77 46,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.